ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Estrella Immunopharma Inc

Estrella Immunopharma Inc (ESLA)

1,1723
0,0623
(5,61%)
Geschlossen 30 Januar 10:00PM
1,1723
0,00
(0,00%)
Nach Börsenschluss: 11:17PM

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
1,1723
Gebot
1,10
Fragen
1,17
Volumen
1.354
1,0361 Tagesbereich 1,1723
0,63 52-Wochen-Bereich 3,23
Marktkapitalisierung
Handelsende
1,11
Handelsbeginn
1,10
Letzte Trade
4
@
1.16
Letzter Handelszeitpunkt
Finanzvolumen
US$ 1.420
VWAP
1,0485
Durchschnittliches Volumen (3 Mio.)
30.928
Ausgegebene Aktien
36.179.147
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-5,79
Gewinn pro Aktie (EPS)
-0,2
Erlöse
-
Nettogewinn
-7,31M

Über Estrella Immunopharma Inc

TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. TradeUP Acquisition Corp is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Estrella Immunopharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ESLA. The last closing price for Estrella Immunopharma was US$1,11. Over the last year, Estrella Immunopharma shares have traded in a share price range of US$ 0,63 to US$ 3,23.

Estrella Immunopharma currently has 36.179.147 shares in issue. The market capitalisation of Estrella Immunopharma is US$40,16 million. Estrella Immunopharma has a price to earnings ratio (PE ratio) of -5.79.

ESLA Neueste Nachrichten

Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) (“Estrella” or the “Company”), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS® T-cell therapies to treat...

Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member

Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) ("Estrella", “Estrella Immunopharma”, or the "Company"), a clinical stage biopharmaceutical company focused on developing CD19 and CD22-targeted...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.05234.669642857141.121.191.0686471.13452051CS
4-0.0277-2.308333333331.21.31651.02119961.17550312CS
120.322337.91764705880.851.4850.695101309281.19669268CS
26-1.0977-48.35682819382.272.550.63838441.20285262CS
52-0.0477-3.909836065571.223.230.63702981.42057076CS
156-4.0377-77.49904030715.215.620.63735691.5541104CS
260-4.0377-77.49904030715.215.620.63735691.5541104CS

ESLA - Frequently Asked Questions (FAQ)

What is the current Estrella Immunopharma share price?
The current share price of Estrella Immunopharma is US$ 1,1723
How many Estrella Immunopharma shares are in issue?
Estrella Immunopharma has 36.179.147 shares in issue
What is the market cap of Estrella Immunopharma?
The market capitalisation of Estrella Immunopharma is USD 40,16M
What is the 1 year trading range for Estrella Immunopharma share price?
Estrella Immunopharma has traded in the range of US$ 0,63 to US$ 3,23 during the past year
What is the PE ratio of Estrella Immunopharma?
The price to earnings ratio of Estrella Immunopharma is -5,79
What is the reporting currency for Estrella Immunopharma?
Estrella Immunopharma reports financial results in USD
What is the latest annual profit for Estrella Immunopharma?
The latest annual profit of Estrella Immunopharma is USD -7,31M
What is the registered address of Estrella Immunopharma?
The registered address for Estrella Immunopharma is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801
Which industry sector does Estrella Immunopharma operate in?
Estrella Immunopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
DGNXDiginex Ltd
US$ 49,18
(228,09%)
3,34M
SLXNSilexion Therapeutics Corporation
US$ 3,1301
(131,86%)
330,45M
KRKR36Kr Holdings Inc
US$ 9,10
(114,12%)
23,61M
SPGCSacks Parente Golf Inc
US$ 0,6001
(57,92%)
52,17M
XFORX4 Pharmaceuticals Inc
US$ 0,7542
(56,54%)
42,5M
ZKINZK International Group Co Ltd
US$ 0,4813
(-41,21%)
3,1M
MGOLMGO Global Inc
US$ 0,1019
(-38,73%)
70,52M
BACKIMAC Holdings Inc
US$ 0,7869
(-35,50%)
2,37M
EYENEyenovia Inc
US$ 0,03695
(-35,18%)
25,31M
HAOHaoxi Health Technology Ltd
US$ 2,52
(-31,89%)
484,94k
NVDANVIDIA Corporation
US$ 123,70
(-4,10%)
466,94M
SLXNSilexion Therapeutics Corporation
US$ 3,1301
(131,86%)
330,45M
OCEAOcean Biomedical Inc
US$ 0,249929
(-24,26%)
186,52M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,428
(-6,98%)
148,12M
RIMEAlgorhythm Holdings Inc
US$ 0,0259
(-16,18%)
138,96M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock